Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus- An Analysis from the UK NHS Perspective
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2090
https://www.valueinhealthjournal.com/article/S1098-3015(15)04166-2/fulltext
Title :
Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus- An Analysis from the UK NHS Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04166-2&doi=10.1016/j.jval.2015.09.2090
First page :
A606
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1509